Crypto Crusader here with an extremely speculative pick, a weed stock, to be exact Cronos Group.
I don't have the time to discuss a more detailed analysis, but I'll post this chart to explain my thinking regarding technicals.
In regards to fundamentals, Altria (the maker of Marlboro) owns just under 50% of Cronos Group. You have to wonder, the maker of the worlds most popular cigarettes (regardless of tobacco being an addictive substance) must have a top notch marketing team behind them. They have billions of dollars, and it's in their best interest to see their investments profit. I'm sure they have a plan for Cronos. This is going to be almost purely speculative as a short / medium term investment, I would expect 50%+- swings in either direction. My entry was around $7.5, lets see how high this stonnkk can go!
May the trading God's be in your favor!
Crypto Crusader
I don't have the time to discuss a more detailed analysis, but I'll post this chart to explain my thinking regarding technicals.
In regards to fundamentals, Altria (the maker of Marlboro) owns just under 50% of Cronos Group. You have to wonder, the maker of the worlds most popular cigarettes (regardless of tobacco being an addictive substance) must have a top notch marketing team behind them. They have billions of dollars, and it's in their best interest to see their investments profit. I'm sure they have a plan for Cronos. This is going to be almost purely speculative as a short / medium term investment, I would expect 50%+- swings in either direction. My entry was around $7.5, lets see how high this stonnkk can go!
May the trading God's be in your favor!
Crypto Crusader
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
